Ze-Yu Yu

Ze-Yu Yu

Auto-generated profile, based on publicly available information

Ze-Yu Yu

Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, No. 11 Bei San Huan Dong Lu, Chaoyang District, Beijing 100029, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2021 in Integrative Medicine Research
Verified
Journal Article
Open access
SZSi-Jia Zhu
Si-Jia Zhu
RWRui-Ting Wang
Rui-Ting Wang
ZYZe-Yu Yu
Ze-Yu Yu
RZRuo-Xiang Zheng
Ruo-Xiang Zheng
CLChang-Hao Liang
Chang-Hao Liang
JLJian-Ping Liu
Jian-Ping Liu
Myasthenia Gravis (MG) is a disorder of neuromuscular transmission bringing mild ocular weakness to severe generalized muscle weakness and disability. The conventional treatments have long-term side effects, and Chinese herbal medicines (CHM) have shown possible effect and safety for MG patients, but the existing evidence was not robust enough and the results were out of date. Searching for randomized controlled trials (RCTs) was conducted in 7 databases and clinical trial registries until July 2021. The ROB 2 tool was used to assess the study quality and GRADE was used to assess the quality of whole evidence. Meta-analyses were conducted and the results were presented as risk ratio (RR) or mean difference (MD) with 95% confidence interval (CI). Nineteen RCTs (1283 participants) testing 13 kinds of CHM with adequate randomization were included and six RCTs investigating Compound Huangqi were included in the meta-analyses. In addition to conventional treatment, nine CHMs reduced symptom scores of MG. Compound Huangqi plus conventional treatment (pyridostigmine bromide or prednisone or both) reduced the symptom scores compared with conventional treatment (MD = -3.56, 95%CI -4.86 to -2.26). Less adverse events happened in the CHM groups (3/247 in the CHM groups, 52/245 in the control groups, RR = 0.13, 95%CI 0.06 to 0.30, 9 RCTs, a total of 492 participants). The effect on quality of life was inconsistent. Nine CHMs could probably bring benefit for MG symptom improvement. Moderate to low certainty of evidence supported Compound Huangqi added-on conventional treatment probably bring extra benefit of improving MG symptoms. Adding CHMs could be safer than giving only conventional treatment. The protocol was registered in PROSPERO (ID: 32718).

18 February 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YJYue Jiang
Yue Jiang
RZRuo-Xiang Zheng
Ruo-Xiang Zheng
ZYZe-Yu Yu
Ze-Yu Yu
XZXiao-Wen Zhang
Xiao-Wen Zhang
JLJing Li
Jing Li
JLJian-Ping Liu
Jian-Ping Liu
Background. Herpes zoster (HZ) is a common infection in individuals with acquired immunodeficiency syndrome (AIDS) patients. Traditional Chinese medicine (TCM) has been used widely in clinical practice for HZ, which remains not supportive of evidence. This review aimed to evaluate the effectiveness and safety of TCM in treating HIV-associated HZ. Methods. Nine electronic databases were searched for randomized controlled trials (RCTs) testing TCM in treating HIV-associated HZ. Data were extracted on citations, interventions, and outcomes, by two authors independently. For the quality evaluation, Cochrane risk-of-bias tool 2.0 was used. Meta-analyses were performed by Revman5.3 software. Effect estimation presented as risk ratio (RR) for dichotomous data and mean difference (MD) for continuous data with their 95 confidence interval (CI). Results. Twelve RCTs (n=644) were included; the majority of them had a high or unclear risk of bias. Meta-analysis showed that pain intensity (VAS 05) in the Chinese herbal medicine (CHM) group was lower than it in the drugs group (MD=0.87, 95 CI [1.69, 0.04], two trials, n=93). Duration of herpes-related pain (days) of patients in the combination group was shorter than those in the drugs group (MD=9.19, 95 CI [16.73, 1.65], n=144). The incidence of postherpetic neuralgia (PHN) in the combination group was lower than in the drugs group (RR=0.49, 95 CI [0.25, 0.99], n=202). As for cure rate (complete absence of pain and herpes), two trials showed that CHM was better than drugs (RR=1.58, 95 CI [1.13, 2.22], n=93), five trials showed combination treatment was better than drugs (RR=1.40, 95 CI [1.08, 1.82], n=224). The cure rate in the acupuncture group was more than that in the drugs group (RR=1.99, 95 CI [1.18, 3.36], n=120). Four trials reported adverse effects and found no serious adverse events occurred. Conclusion. CHM and acupuncture demonstrate more benefits than drugs in pain relief, cure rate improvement, and incidence reduction of PHN. However, given the data limitation and TCM therapies diversity, the conclusions need to be verified in future trials.

1 October 2021 in European Journal of Integrative Medicine
Verified
Journal Article
Open access
YZYing-Ying Zhang
Ying-Ying Zhang
ZYZe-Yu Yu
Ze-Yu Yu
HLHui-Di Lan
Hui-Di Lan
SLShi-Bing Liang
Shi-Bing Liang
MFMin Fang
Min Fang
JLJian-Ping Liu
Jian-Ping Liu